NEWS

Nov 22, 2005

FDA names new director for office of women's health

The U.S. Food and Drug Administration (FDA) yesterday announced it has appointed Kathleen Uhl, as the new Director of FDA's Office of Women's Health (OWH). Dr. Uhl, most recently served as a Supervisory Medical Officer in FDA's Center for Drug Evaluation and Research (CDER).

Uhl, who will begin the job in mid-December, will oversee programs that aim to: ensure FDA functions are gender sensitive and responsive; correct any gender disparities in medical product testing and regulation policy; monitor the progress of women's health initiatives within FDA; and form partnerships with government and non-government groups to promote women's health objectives.